comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 13:59:29 - browse：3644

Adam's take main illustration — Molly Ferguson/STAT

I am one week away from the launch of my weekly email newsletter! It’s called Adam’s Biotech Scorecard, and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at [email protected].

This week: A preview of Intra-Cellular Therapies’ Phase 3 study in major depressive disorder, and a couple of liver-disease physician perspectives on Rezdiffra, the newly approved treatment for MASH from Madrigal Pharmaceuticals.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Skip the lead apron during X

WSS

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Report cites 'urgent' need to recruit more diverse clinical trial participants

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Juul documents reveal insider tactics on political lobbying

Vertex cell therapy lets patients with type 1 diabetes stop insulin

Crowdfunding for unproven stem cell procedures spreads misinformation

focus

comprehensive

knowledge

Medicare proposal to cover medical devices draws a mixed reaction

Having children helps parents live longer, especially after age 80

Dobbs anniversary: the lost opportunity of abortion as health care

Undocumented workers face uncertainty as immigration law takes effect in Florida

Medical records are filled with copy

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Medicare proposal to cover medical devices draws a mixed reaction

Beware reading your test results before your doctor does

After affirmative action ruling, medical educators look to 'holistic review'

The biotech scorecard for Q3: 15 stock

focus

Having children helps parents live longer, especially after age 80

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Canadians with cystic fibrosis outlive Americans by a decade

Congress might make insulin pumps more accessible to the blind

Dexcom's push to bring CGM to type 2 diabetes patients

A letter from the executive editor: The 2023 STATUS List

hotspot

focus

Wikipedia

knowledge